Yellow fever revaccination during infliximab therapy

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Arthritis care & research

• Publication date

  2010-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/acr.20045PMID 20535801
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010

  2011cited by this paper
• Clinical and epidemiological research

  2011cited by this paper
• The effect of infliximab and timing of vaccination on the humoral response to influenza vaccination in patients with rheumatoid arthritis and ankylosing spondylitis.

  2010cited by this paper
• Submissions invited for themed issue of Arthritis Care & Research: Vascular comorbidity in the rheumatic diseases

  2010cited by this paper
• Immunization of patients with rheumatoid arthritis with antitumor necrosis factorα therapy and methotrexate

  2008cited by this paper
• Protective immunity following vaccination: How is it defined?

  2008cited by this paper
• Vaccination contre la fièvre jaune en dehors des sujets immunocompétents Yellow fever vaccination in non-immunocompetent patients

  2008cited by this paper
• Yellow fever vaccine: past, present and future

  2008cited by this paper
• [Yellow fever vaccination in non-immunocompetent patients].

  2008cited by this paper
• Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008

  2008cited by this paper
• Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses

  2008cited by this paper
• Yellow fever: epidemiology and prevention.

  2007cited by this paper
• Evaluation of an Indirect Immunofluorescence Assay for Detection of Immunoglobulin M (IgM) and IgG Antibodies against Yellow Fever Virus

  2007influential reference
• Duration of humoral immunity to common viral and vaccine antigens.

  2007cited by this paper
• Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients.

  2006cited by this paper
• Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNFα blockers

  2005cited by this paper
• [Yellow fever (epidemiology and prevention)].

  1983cited by this paper

• Immunisation against vaccine-preventable diseases in individuals receiving immunosuppressive targeted therapies.

  2026cites this paper
• Infection Risk and Vaccination in the Management of Psoriasis: Considerations for Biologic Therapy

  2025cites this paper
• Advising the immunocompromised traveller: a review of immunocompromise at The London Hospital for Tropical Diseases Travel Clinic between 1st April 2019 and 30th April 2020

  2024cites this paper
• Expert Panel Consensus Statements on Vaccination for Adults with AIRD in India

  2024cites this paper
• Methotrexate and immunogenicity of vaccines in patients with rheumatic diseases

  2024cites this paper
• Vaccinology in pediatric rheumatology: Past, present and future

  2023cites this paper
• Impact of methotrexate treatment on vaccines immunogenicity in adult rheumatological patients - Lessons learned from the COVID-19 pandemic.

  2023cites this paper
• 2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases

  2023cites this paper
• 2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases

  2023cites this paper
• Response to Vaccines in Patients with Immune-Mediated Inflammatory Diseases: A Narrative Review

  2022cites this paper
• Efficacy, Immunogenicity and Safety of Vaccination in Pediatric Patients With Autoimmune Inflammatory Rheumatic Diseases (pedAIIRD): A Systematic Literature Review for the 2021 Update of the EULAR/PRES Recommendations

  2022cites this paper
• Yellow fever vaccine safety in immunocompromised individuals: a systematic review and meta-analysis.

  2022cites this paper
• Seroconversion of rheumatoid arthritis patients after yellow fever vaccination

  2021cites this paper
• An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology

  2021cites this paper
• Adverse events following yellow fever vaccination in immunocompromised persons

  2021cites this paper
• Vaccination in Children With Autoimmune Disorders and Treated With Various Immunosuppressive Regimens: A Comprehensive Review and Practical Guide

  2021cites this paper
• Anti-inflammatory drugs and immunogenicity of vaccines in patients with rheumatic diseases

  2021cites this paper
• Impact of disease-modifying antirheumatic drugs on vaccine immunogenicity in patients with inflammatory rheumatic and musculoskeletal diseases

  2021cites this paper
• Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations

  2019cites this paper
• Emergent Arboviruses and Renal Transplantation: A Global Challenge

  2019cites this paper
• Brazilian recommendations on the safety and effectiveness of the yellow fever vaccination in patients with chronic immune-mediated inflammatory diseases

  2019cites this paper
• 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

  2019cites this paper
• Vaccination rate and immunity of children and adolescents with inflammatory bowel disease or autoimmune hepatitis in Germany.

  2019cites this paper
• Vaccination Guidelines for Patients With Immune-Mediated Disorders on Immunosuppressive Therapies

  2018cites this paper
• Zweiter österreichischer Konsensus zur sicheren Anwendung von anti-TNF-α-Antikörpern bei chronisch-entzündlichen Darmerkrankungen

  2018cites this paper
• Vacunación en pacientes con enfermedades reumatológicas

  2018cites this paper
• Safety of live vaccines on immunosuppressive or immunomodulatory therapy—a retrospective study in three Swiss Travel Clinics

  2018cites this paper
• Reintroducing OPV in Israel on the journey to global polio eradication - Estimation at a low rate of contraindicated population.

  2018cites this paper
• Yellow fever vaccine and risk of developing serious adverse events: a systematic review

  2018cites this paper
• Vaccination Recommendations for Adults With Autoimmune Inflammatory Rheumatic Diseases in Latin America

  2017cites this paper
• Vaccines and Disease-Modifying Antirheumatic Drugs: Practical Implications for the Rheumatologist.

  2017cites this paper
• Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow transplantation - A systematic review of randomized trials, observational studies and case reports.

  2017cites this paper
• REFORÇO VACINAL EM VIGÊNCIA DE ADALIMUMABE: UM RELATO DE CASO E REVISÃO DE LITERATURA

  2017cites this paper
• Inadvertent yellow fever vaccination of a patient with Crohn's disease treated with infliximab and methotrexate

  2016cites this paper
• Yellow fever vaccination during treatment with infliximab in a patient with ulcerative colitis: A case report

  2016cites this paper
• Autoimmune disease and vaccination: impact on infectious disease prevention and a look at future applications.

  2016cites this paper
• Vacunación en pacientes con enfermedades

  2016cites this paper
• Management and Prevention of Herpes Zoster in the Immunocompromised Inflammatory Bowel Disease Patient: A Clinical Quandary

  2016cites this paper
• Vaccinations des patients traités par immunosuppresseurs, biothérapie et/ou corticothérapie pour une maladie auto-immune ou inflammatoire chronique

  2016cites this paper
• Vaccinations for rheumatoid arthritis

  2016cites this paper
• Recommendations for Vaccination in Adult Patients with Systemic Inflammatory Rheumatic Diseases from the Portuguese Society of Rheumatology.

  2016cites this paper
• [Not Available].

  2016cites this paper
• Yellow Fever Vaccination of a Primary Vaccinee During Adalimumab Therapy.

  2015cites this paper
• Vaccination recommendations for adult patients with autoimmune inflammatory rheumatic diseases.

  2015cites this paper
• Vaccinations in Paediatric Rheumatology: an Update on Current Developments

  2015cites this paper
• Recommendations for the management of autoinflammatory diseases

  2015cites this paper
• Vaccinations in Rheumatoid Arthritis

  2015cites this paper
• Yellow Fever Vaccine and Autoimmunity

  2015cites this paper
• Gelbfieberimpfung bei medikamentöser Immunsuppression – Aktuelle Empfehlungen für die reisemedizinische Beratung

  2014cites this paper
• Live viral vaccines in immunocompromised patients

  2014cites this paper
• Effects of biological and non-biological immunomodulatory therapies on the immunogenicity of vaccines in patients with rheumatic diseases

  2014cites this paper
• The comparative safety of tumor necrosis factor inhibitors in rheumatoid arthritis: a meta-analysis update of 44 trials.

  2014cites this paper
• Effects of the live attenuated measles-mumps-rubella booster vaccination on disease activity in patients with juvenile idiopathic arthritis: a randomized trial.

  2013cites this paper
• Consenso 2012 da Sociedade Brasileira de Reumatologia sobre vacinação em pacientes com artrite reumatoide

  2013cites this paper
• O que o reumatologista deve saber sobre a vacina contra febre amarela

  2013cites this paper
• Vacunación en pacientes con enfermedades reumatológicas

  2013cites this paper
• Vaccination of immunocompromised travelers: need for specific recommendations!

  2013cites this paper
• 2012 Brazilian Society of Rheumatology Consensus on vaccination of patients with rheumatoid arthritis.

  2013cites this paper
• Safety and Immunogenicity of Yellow Fever 17D Vaccine in Adults Receiving Systemic Corticosteroid Therapy: An Observational Cohort Study

  2013cites this paper
• What a rheumatologist needs to know about yellow fever vaccine.

  2013cites this paper
• Travel Medicine and Transplant Tourism in Solid Organ Transplantation

  2013cites this paper
• The immunosuppressed traveler.

  2012cites this paper
• Yellow fever vaccination in organ transplanted patients: is it safe? A multicenter study

  2012cites this paper
• Brazilian Society of Rheumatology Consensus for the treatment of rheumatoid arthritis

  2012cites this paper
• EULAR recommendations for vaccination in paediatric patients with rheumatic diseases

  2011cites this paper
• TNF-α Antagonists and Immunization

  2011cites this paper
• The use, safety, and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: a longitudinal observational study

  2011cites this paper